Proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding [3]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 11, 2006, Pages 1763-1765

  Leontiadis, Grigoris I ^a   Sharma, Virender K ^b   Howden, Colin W ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MAYO CLINIC   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR; SOMATOSTATIN;

ANALYSIS; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; DEATH; HUMAN; LETTER; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; PUBLICATION; RANDOMIZATION; RELIABILITY; UPPER GASTROINTESTINAL BLEEDING;

EID: 33748787667     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04177.x     Document Type: Letter

References (14)

1. Khuroo MS, Khuroo MS, Farahat KLC, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J. Gastroenterol. Hepatol. 2005; 20: 11-25.
2. Leontiadis GI, McIntyre L, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst. Rev. 2004, Issue 3. Art. No.: CD002094.pub2. DOI: 10.1002/14651858.CD002094.pub2.
3. Leontiadis GI, Sharma VK, Howden CW. Cochrane Collaboration systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ 2005; 330: 568-70.
4. Chua RT, Lin HJ, Wang K et al. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study. Chung Hua I Hsueh Tsa Chih (Taipei) 1996; 57: 139-45.
5. Lin HJ, Lo WC, Perng CL et al. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non bleeding visible vessel: a preliminary report of a randomised comparative study. Hepatogastroenterology 1997; 44: 1495-9.
6. 2 receptor antagonists?]. Z. Gastroenterol. 1995; 33: 431-4. (In German).
7. Goletti O, Sidoti F, Lippolis PV et al. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial. Ital. J. Gastroenterol. 1994; 26: 72-4.
8. Kaviani MJ, Hashemi MR, Kazemifar AR et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double blind, randomized, clinical trial. Aliment. Pharmacol. Ther. 2003; 17: 211-16.
9. Sheu BS, Chi CH, Huang CC et al. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment. Pharmacol. Ther. 2002; 16: 137-43.
10. Duvnjak M, Supanc V, Troskot B et al. Comparison of intravenous pantoprazole with intravenous ranitidine in prevention of rebleeding from gastroduodenal ulcers. Gut 2001; 49 (Suppl. III): Abstract 2379.
11. Daneshmend TK, Hawkey CJ, Langman MJS et al. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992; 304: 143-7.
12. Brunner G, Chang J. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper gastrointestinal tract: an open randomized controlled study. Digestion 1990; 45: 217-25.
13. Lin HJ, Lo WC, Lee FY et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch. Intern. Med. 1998; 158: 54-8.
14. Lau JY, Sung JJ, Lee KK et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N. Eng. J. Med. 2000; 343: 310-16.